{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T23:01:17Z","timestamp":1794610877451,"version":"4.9.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,30]],"date-time":"2020-03-30T00:00:00Z","timestamp":1585526400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,3,30]],"date-time":"2020-03-30T00:00:00Z","timestamp":1585526400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000860","name":"European Society of Cardiology","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000860","id-type":"DOI","asserted-by":"crossref"}]},{"name":"German Ministry of Education and Research"},{"name":"Graduate School of Life Sciences of the University of W\u00fcrzburg"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Tobacco smoking is one of the most important risk factors of coronary heart disease (CHD). Hence, smoking cessation is considered pivotal in the prevention of CHD. The current study aimed to evaluate smoking cessation patterns and determine factors associated with smoking cessation in patients with established CHD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The fourth European Survey of Cardiovascular Disease Prevention and Diabetes investigated quality of CHD care in 24 countries across Europe in 2012\/13. In the German subset, smoking cessation patterns and clinical characteristics were repetitively assessed a) during index event due to CHD by medical record abstraction, b) as part of a face-to-face interview 6 to 36\u2009months after the index event (i.e. baseline visit), and c) by telephone-based follow-up interview two years after the baseline visit. Logistic regression analysis was performed to search for factors determining smoking status at the time of the telephone interview.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Out of 469 participants available for follow-up, 104 (22.2%) had been classified as current smokers at the index event. Of those, 65 patients (62.5%) had quit smoking at the time of the telephone interview, i.e., after a median observation period of 3.5\u2009years (quartiles 3.0, 4.1). Depressed mood at baseline visit and higher education level were less prevalent amongst quitters vs non-quitters (17.2% vs 35.9%, <jats:italic>p<\/jats:italic>\u2009=\u20090.03 and 15.4% vs 33.3%, p\u2009=\u20090.03), cardiac rehabilitation programs were more frequently attended by quitters (83.1% vs 48.7%, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), and there was a trend for a higher prevalence of diabetes at baseline visit in quitters (37.5% vs 20.5%, <jats:italic>p<\/jats:italic>\u2009=\u20090.07). In the final multivariable model, cardiac rehabilitation was associated with smoking cessation (OR 5.19; 95%CI 1.87 to 14.46; <jats:italic>p<\/jats:italic>\u2009=\u20090.002).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>Attending a cardiac rehabilitation program after a cardiovascular event was associated with smoking cessation supporting its use as a platform for smoking cessation counseling and relapse prevention.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12872-020-01429-w","type":"journal-article","created":{"date-parts":[[2020,3,30]],"date-time":"2020-03-30T19:04:49Z","timestamp":1585595089000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Factors associated with smoking cessation in patients with coronary heart disease: a cohort analysis of the German subset of EuroAspire IV survey"],"prefix":"10.1186","volume":"20","author":[{"name":"on behalf of the German EUROASPIRE IV collaborators","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Goettler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Faller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Kotseva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Leyh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Ertl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Karmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. U.","family":"Heuschmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"St\u00f6rk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,30]]},"reference":[{"issue":"10010","key":"1429_CR1","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1016\/S0140-6736(15)00128-2","volume":"386","author":"MH Forouzanfar","year":"2015","unstructured":"G. B. D. Risk Factors Collaborators, Forouzanfar MH, Alexander L, Anderson HR, Bachman VF, Biryukov S, Brauer M, Burnett R, Casey D, Coates MM, et al. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386(10010):2287\u2013323. https:\/\/doi.org\/10.1016\/S0140-6736(15)00128-2.","journal-title":"Lancet"},{"issue":"1","key":"1429_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jacc.2017.04.052","volume":"70","author":"GA Roth","year":"2017","unstructured":"Roth GA, Johnson C, Abajobir A, Abd-Allah F, Abera SF, Abyu G, Ahmed M, Aksut B, Alam T, Alam K, et al. Global, regional, and National Burden of cardiovascular diseases for 10 causes, 1990 to 2015. J Am Coll Cardiol. 2017;70(1):1\u201325. https:\/\/doi.org\/10.1016\/j.jacc.2017.04.052.","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"1429_CR3","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1001\/archinte.160.7.939","volume":"160","author":"K Wilson","year":"2000","unstructured":"Wilson K, Gibson N, Willan A, Cook D. Effect of smoking cessation on mortality after myocardial infarction: meta-analysis of cohort studies. Arch Intern Med. 2000;160(7):939\u201344. https:\/\/doi.org\/10.1001\/archinte.160.7.939.","journal-title":"Arch Intern Med"},{"issue":"6","key":"1429_CR4","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1161\/CIRCULATIONAHA.109.891523","volume":"121","author":"CK Chow","year":"2010","unstructured":"Chow CK, Jolly S, Rao-Melacini P, Fox KA, Anand SS, Yusuf S. Association of diet, exercise, and smoking modification with risk of early cardiovascular events after acute coronary syndromes. Circulation. 2010;121(6):750\u20138. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.109.891523.","journal-title":"Circulation."},{"issue":"29","key":"1429_CR5","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1093\/eurheartj\/ehw106","volume":"37","author":"MF Piepoli","year":"2016","unstructured":"Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, Cooney MT, Corra U, Cosyns B, Deaton C, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J. 2016;37(29):2315\u201381. https:\/\/doi.org\/10.1093\/eurheartj\/ehw106.","journal-title":"Eur Heart J"},{"issue":"4","key":"1429_CR6","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.gheart.2015.11.003","volume":"12","author":"K Kotseva","year":"2017","unstructured":"Kotseva K, De Bacquer D, Jennings C, Gyberg V, De Backer G, Ryden L, Amouyel P, Bruthans J, Cifkova R, Deckers JW, et al. Time trends in lifestyle, risk factor control, and use of evidence-based medications in patients with coronary heart disease in Europe: results from 3 EUROASPIRE surveys, 1999-2013. Glob Heart. 2017;12(4):315\u201322 e313. https:\/\/doi.org\/10.1016\/j.gheart.2015.11.003.","journal-title":"Glob Heart"},{"issue":"1","key":"1429_CR7","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/1471-2261-14-133","volume":"14","author":"F Hammal","year":"2014","unstructured":"Hammal F, Ezekowitz JA, Norris CM, Wild TC, Finegan BA, Approach investigators. Smoking status and survival: impact on mortality of continuing to smoke one year after the angiographic diagnosis of coronary artery disease, a prospective cohort study. BMC Cardiovasc Disord. 2014;14(1):133. https:\/\/doi.org\/10.1186\/1471-2261-14-133.","journal-title":"BMC Cardiovasc Disord"},{"issue":"18","key":"1429_CR8","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1001\/archinte.168.18.1961","volume":"168","author":"N Dawood","year":"2008","unstructured":"Dawood N, Vaccarino V, Reid KJ, Spertus JA, Hamid N, Parashar S, Premier registry investigators. Predictors of smoking cessation after a myocardial infarction: the role of institutional smoking cessation programs in improving success. Arch Intern Med. 2008;168(18):1961\u20137. https:\/\/doi.org\/10.1001\/archinte.168.18.1961.","journal-title":"Arch Intern Med"},{"issue":"6","key":"1429_CR9","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1177\/2047487315569401","volume":"23","author":"K Kotseva","year":"2016","unstructured":"Kotseva K, Wood D, De Bacquer D, De Backer G, Ryden L, Jennings C, Gyberg V, Amouyel P, Bruthans J, Castro Conde A, et al. EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries. Eur J Prev Cardiol. 2016;23(6):636\u201348. https:\/\/doi.org\/10.1177\/2047487315569401.","journal-title":"Eur J Prev Cardiol"},{"issue":"3","key":"1429_CR10","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s12529-017-9691-y","volume":"25","author":"M Wagner","year":"2018","unstructured":"Wagner M, Gelbrich G, Kircher J, Kotseva K, Wood D, Morbach C, Leyh R, Ertl G, Karmann W, Stork S, et al. Secondary prevention in younger vs. older coronary heart disease patients-insights from the German subset of the EUROASPIRE IV survey. Int J Behav Med. 2018;25(3):283\u201393. https:\/\/doi.org\/10.1007\/s12529-017-9691-y.","journal-title":"Int J Behav Med"},{"issue":"3","key":"1429_CR11","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s10654-018-0454-0","volume":"34","author":"D De Bacquer","year":"2019","unstructured":"De Bacquer D, De Smedt D, Kotseva K, Jennings C, Wood D, Ryden L, Gyberg V, Shahim B, Amouyel P, Bruthans J, et al. Incidence of cardiovascular events in patients with stabilized coronary heart disease: the EUROASPIRE IV follow-up study. Eur J Epidemiol. 2019;34(3):247\u201358. https:\/\/doi.org\/10.1007\/s10654-018-0454-0.","journal-title":"Eur J Epidemiol"},{"issue":"39","key":"1429_CR12","doi-asserted-by":"publisher","first-page":"3035","DOI":"10.1093\/eurheartj\/eht108","volume":"34","author":"L Ryden","year":"2013","unstructured":"Authors\/Task Force, Members, Ryden L, Grant PJ, Anker SD, Berne C, Cosentino F, Danchin N, Deaton C, Escaned J, Hammes HP, et al. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD). Eur Heart J. 2013;34(39):3035\u201387. https:\/\/doi.org\/10.1093\/eurheartj\/eht108.","journal-title":"Eur Heart J"},{"issue":"2","key":"1429_CR13","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/s0022-3999(01)00296-3","volume":"52","author":"I Bjelland","year":"2002","unstructured":"Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the hospital anxiety and depression scale. An updated literature review. J Psychosom Res. 2002;52(2):69\u201377. https:\/\/doi.org\/10.1016\/s0022-3999(01)00296-3.","journal-title":"J Psychosom Res"},{"key":"1429_CR14","doi-asserted-by":"publisher","unstructured":"Tiffe T, Morbach C, Malsch C, Gelbrich G, Wahl V, Wagner M, Kotseva K, Wood D, Leyh R, Ertl G, et al. Physicians' lifestyle advice on primary and secondary cardiovascular disease prevention in Germany: a comparison between the STAAB cohort study and the German subset of EUROASPIRE IV. Eur J Prev Cardiol. 2019;2047487319838218. https:\/\/doi.org\/10.1177\/2047487319838218.","DOI":"10.1177\/2047487319838218"},{"issue":"4","key":"1429_CR15","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.amjcard.2014.11.020","volume":"115","author":"O Sochor","year":"2015","unstructured":"Sochor O, Lennon RJ, Rodriguez-Escudero JP, Bresnahan JF, Croghan I, Somers VK, Lopez-Jimenez F, Pack Q, Thomas RJ. Trends and predictors of smoking cessation after percutaneous coronary intervention (from Olmsted County, Minnesota, 1999 to 2010). Am J Cardiol. 2015;115(4):405\u201310. https:\/\/doi.org\/10.1016\/j.amjcard.2014.11.020.","journal-title":"Am J Cardiol"},{"issue":"9667","key":"1429_CR16","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/S0140-6736(09)60330-5","volume":"373","author":"K Kotseva","year":"2009","unstructured":"Kotseva K, Wood D, De Backer G, De Bacquer D, Pyorala K, Keil U, Euroaspire Study Group. Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries. Lancet. 2009;373(9667):929\u201340. https:\/\/doi.org\/10.1016\/S0140-6736(09)60330-5.","journal-title":"Lancet."},{"key":"1429_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005992.pub3","volume":"2","author":"K Frazer","year":"2016","unstructured":"Frazer K, Callinan JE, McHugh J, van Baarsel S, Clarke A, Doherty K, Kelleher C. Legislative smoking bans for reducing harms from secondhand smoke exposure, smoking prevalence and tobacco consumption. Cochrane Database Syst Rev. 2016;2:CD005992. https:\/\/doi.org\/10.1002\/14651858.CD005992.pub3.","journal-title":"Cochrane Database Syst Rev"},{"key":"1429_CR18","unstructured":"World Health Organization. WHO framework convention on tobacco control. Geneva; 2003. Available at [https:\/\/www.who.int\/fctc\/en\/]. Accessed 25 February 2020."},{"issue":"9","key":"1429_CR19","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1177\/2047487313483610","volume":"21","author":"J Schmucker","year":"2014","unstructured":"Schmucker J, Wienbergen H, Seide S, Fiehn E, Fach A, Wurmann-Busch B, Gohlke H, Gunther K, Ahrens W, Hambrecht R. Smoking ban in public areas is associated with a reduced incidence of hospital admissions due to ST-elevation myocardial infarctions in non-smokers. Results from the Bremen STEMI registry. Eur J Prev Cardiol. 2014;21(9):1180\u20136. https:\/\/doi.org\/10.1177\/2047487313483610.","journal-title":"Eur J Prev Cardiol"},{"issue":"2","key":"1429_CR20","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.amepre.2008.04.009","volume":"35","author":"The Clinical Practice Guideline Treating Tobacco Use and Dependence 2008 Update Panel, Liaisons, and Staff","year":"2008","unstructured":"The Clinical Practice Guideline Treating Tobacco Use and Dependence 2008 Update Panel, Liaisons, and Staff. A clinical practice guideline for treating tobacco use and dependence: 2008 update. A U.S. Public Health Service report. Am J Prev Med. 2008;35(2):158\u201376. https:\/\/doi.org\/10.1016\/j.amepre.2008.04.009.","journal-title":"Am J Prev Med"},{"issue":"12","key":"1429_CR21","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1136\/thorax.55.12.987","volume":"55","author":"R West","year":"2000","unstructured":"West R, McNeill A, Raw M. Smoking cessation guidelines for health professionals: an update. Health Education Authority. Thorax. 2000;55(12):987\u201399. https:\/\/doi.org\/10.1136\/thorax.55.12.987.","journal-title":"Thorax"},{"key":"1429_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000146.pub3","volume":"1","author":"LF Stead","year":"2008","unstructured":"Stead LF, Perera R, Bullen C, Mant D, Lancaster T. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2008;1:CD000146. https:\/\/doi.org\/10.1002\/14651858.CD000146.pub3.","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"1429_CR23","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1053\/euhj.1999.1949","volume":"21","author":"D Balfour","year":"2000","unstructured":"Balfour D, Benowitz N, Fagerstrom K, Kunze M, Keil U. Diagnosis and treatment of nicotine dependence with emphasis on nicotine replacement therapy. A status report. Eur Heart J. 2000;21(6):438\u201345. https:\/\/doi.org\/10.1053\/euhj.1999.1949.","journal-title":"Eur Heart J"},{"issue":"2","key":"1429_CR24","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1093\/eurpub\/cki123","volume":"15","author":"D Twardella","year":"2005","unstructured":"Twardella D, Brenner H. Lack of training as a central barrier to the promotion of smoking cessation: a survey among general practitioners in Germany. Eur J Pub Health. 2005;15(2):140\u20135. https:\/\/doi.org\/10.1093\/eurpub\/cki123.","journal-title":"Eur J Pub Health"},{"issue":"8","key":"1429_CR25","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1177\/2047487315601078","volume":"23","author":"J Bruthans","year":"2016","unstructured":"Bruthans J, Mayer O Jr, De Bacquer D, De Smedt D, Reiner Z, Kotseva K, Cifkova R, Euroaspire IV investigators. Educational level and risk profile and risk control in patients with coronary heart disease. Eur J Prev Cardiol. 2016;23(8):881\u201390. https:\/\/doi.org\/10.1177\/2047487315601078.","journal-title":"Eur J Prev Cardiol"},{"key":"1429_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijcard.2018.01.064","volume":"258","author":"M Snaterse","year":"2018","unstructured":"Snaterse M, Deckers JW, Lenzen MJ, Jorstad HT, De Bacquer D, Peters RJG, Jennings C, Kotseva K, Scholte Op Reimer WJM, Euroaspire investigators. Smoking cessation in European patients with coronary heart disease. Results from the EUROASPIRE IV survey: a registry from the European society of cardiology. Int J Cardiol. 2018;258:1\u20136. https:\/\/doi.org\/10.1016\/j.ijcard.2018.01.064.","journal-title":"Int J Cardiol"},{"issue":"1","key":"1429_CR27","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.addbeh.2013.08.030","volume":"39","author":"RS Caraballo","year":"2014","unstructured":"Caraballo RS, Kruger J, Asman K, Pederson L, Widome R, Kiefe CI, Hitsman B, Jacobs DR Jr. Relapse among cigarette smokers: the CARDIA longitudinal study - 1985-2011. Addict Behav. 2014;39(1):101\u20136. https:\/\/doi.org\/10.1016\/j.addbeh.2013.08.030.","journal-title":"Addict Behav"},{"issue":"3","key":"1429_CR28","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1093\/ntr\/ntx087","volume":"20","author":"J Hoebel","year":"2018","unstructured":"Hoebel J, Kuntz B, Kroll LE, Finger JD, Zeiher J, Lange C, Lampert T. Trends in absolute and relative educational inequalities in adult smoking since the early 2000s: the case of Germany. Nicotine Tob Res. 2018;20(3):295\u2013302. https:\/\/doi.org\/10.1093\/ntr\/ntx087.","journal-title":"Nicotine Tob Res"},{"issue":"2","key":"1429_CR29","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.3390\/ijerph120202135","volume":"12","author":"X Xu","year":"2015","unstructured":"Xu X, Liu L, Sharma M, Zhao Y. Smoking-related knowledge, attitudes, behaviors, smoking cessation idea and education level among young adult male smokers in Chongqing, China. Int J Environ Res Public Health. 2015;12(2):2135\u201349. https:\/\/doi.org\/10.3390\/ijerph120202135.","journal-title":"Int J Environ Res Public Health"},{"issue":"4","key":"1429_CR30","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/s0022-3999(02)00311-2","volume":"53","author":"RM Carney","year":"2002","unstructured":"Carney RM, Freedland KE, Miller GE, Jaffe AS. Depression as a risk factor for cardiac mortality and morbidity: a review of potential mechanisms. J Psychosom Res. 2002;53(4):897\u2013902. https:\/\/doi.org\/10.1016\/s0022-3999(02)00311-2.","journal-title":"J Psychosom Res"},{"issue":"Suppl 1","key":"1429_CR31","doi-asserted-by":"publisher","first-page":"S42","DOI":"10.1097\/01.psy.0000162255.55629.9c","volume":"67","author":"KE Freedland","year":"2005","unstructured":"Freedland KE, Carney RM, Skala JA. Depression and smoking in coronary heart disease. Psychosom Med. 2005;67(Suppl 1):S42\u20136. https:\/\/doi.org\/10.1097\/01.psy.0000162255.55629.9c.","journal-title":"Psychosom Med"},{"issue":"21","key":"1429_CR32","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.110.983536","volume":"123","author":"K Goel","year":"2011","unstructured":"Goel K, Lennon RJ, Tilbury RT, Squires RW, Thomas RJ. Impact of cardiac rehabilitation on mortality and cardiovascular events after percutaneous coronary intervention in the community. Circulation. 2011;123(21):2344\u201352. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.110.983536.","journal-title":"Circulation."},{"issue":"5","key":"1429_CR33","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1177\/2047487312449591","volume":"20","author":"K Kotseva","year":"2013","unstructured":"Kotseva K, Wood D, De Backer G, De Bacquer D, Euroaspire III study group. Use and effects of cardiac rehabilitation in patients with coronary heart disease: results from the EUROASPIRE III survey. Eur J Prev Cardiol. 2013;20(5):817\u201326. https:\/\/doi.org\/10.1177\/2047487312449591.","journal-title":"Eur J Prev Cardiol"},{"key":"1429_CR34","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001800.pub2","volume":"7","author":"BS Heran","year":"2011","unstructured":"Heran BS, Chen JM, Ebrahim S, Moxham T, Oldridge N, Rees K, Thompson DR, Taylor RS. Exercise-based cardiac rehabilitation for coronary heart disease. Cochrane Database Syst Rev. 2011;7:CD001800. https:\/\/doi.org\/10.1002\/14651858.CD001800.pub2.","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"1429_CR35","doi-asserted-by":"publisher","first-page":"659","DOI":"10.7326\/0003-4819-143-9-200511010-00010","volume":"143","author":"AM Clark","year":"2005","unstructured":"Clark AM, Hartling L, Vandermeer B, McAlister FA. Meta-analysis: secondary prevention programs for patients with coronary artery disease. Ann Intern Med. 2005;143(9):659\u201372. https:\/\/doi.org\/10.7326\/0003-4819-143-9-200511010-00010.","journal-title":"Ann Intern Med"},{"issue":"10","key":"1429_CR36","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.amjmed.2004.01.009","volume":"116","author":"RS Taylor","year":"2004","unstructured":"Taylor RS, Brown A, Ebrahim S, Jolliffe J, Noorani H, Rees K, Skidmore B, Stone JA, Thompson DR, Oldridge N. Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials. Am J Med. 2004;116(10):682\u201392. https:\/\/doi.org\/10.1016\/j.amjmed.2004.01.009.","journal-title":"Am J Med"},{"key":"1429_CR37","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001800.pub3","volume":"1","author":"L Anderson","year":"2016","unstructured":"Anderson L, Thompson DR, Oldridge N, Zwisler AD, Rees K, Martin N, Taylor RS. Exercise-based cardiac rehabilitation for coronary heart disease. Cochrane Database Syst Rev. 2016;1:CD001800. https:\/\/doi.org\/10.1002\/14651858.CD001800.pub3.","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"1429_CR38","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1097\/01.hjr.0000199492.00967.11","volume":"13","author":"RS Taylor","year":"2006","unstructured":"Taylor RS, Unal B, Critchley JA, Capewell S. Mortality reductions in patients receiving exercise-based cardiac rehabilitation: how much can be attributed to cardiovascular risk factor improvements? Eur J Cardiovasc Prev Rehabil. 2006;13(3):369\u201374. https:\/\/doi.org\/10.1097\/01.hjr.0000199492.00967.11.","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"issue":"12","key":"1429_CR39","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1177\/2047487318781359","volume":"25","author":"K Kotseva","year":"2018","unstructured":"Kotseva K, Wood D, De Bacquer D, Euroaspire investigators. Determinants of participation and risk factor control according to attendance in cardiac rehabilitation programmes in coronary patients in Europe: EUROASPIRE IV survey. Eur J Prev Cardiol. 2018;25(12):1242\u201351. https:\/\/doi.org\/10.1177\/2047487318781359.","journal-title":"Eur J Prev Cardiol"},{"issue":"9","key":"1429_CR40","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.annepidem.2007.03.013","volume":"17","author":"S Galea","year":"2007","unstructured":"Galea S, Tracy M. Participation rates in epidemiologic studies. Ann Epidemiol. 2007;17(9):643\u201353. https:\/\/doi.org\/10.1016\/j.annepidem.2007.03.013.","journal-title":"Ann Epidemiol"},{"issue":"7","key":"1429_CR41","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.2105\/ajph.84.7.1086","volume":"84","author":"DL Patrick","year":"1994","unstructured":"Patrick DL, Cheadle A, Thompson DC, Diehr P, Koepsell T, Kinne S. The validity of self-reported smoking: a review and meta-analysis. Am J Public Health. 1994;84(7):1086\u201393. https:\/\/doi.org\/10.2105\/ajph.84.7.1086.","journal-title":"Am J Public Health"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-020-01429-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12872-020-01429-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-020-01429-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,29]],"date-time":"2021-03-29T23:16:43Z","timestamp":1617059803000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-020-01429-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,30]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1429"],"URL":"https:\/\/doi.org\/10.1186\/s12872-020-01429-w","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,30]]},"assertion":[{"value":"6 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study conforms with the Declaration of Helsinki. The Ethics Committee of the Medical Faculty of the University of W\u00fcrzburg approved the study (EK Votum 58\/12). Written informed consent was obtained from each participant. Recruitment strategy, data acquisition, and data storage was authorized by the data protection officer at the University of W\u00fcrzburg.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"PUH reports grants from German Ministry of Research and Education, European Union, German Research Foundation, Charit\u00e9\u2013Universit\u00e4tsmedizin Berlin, Berlin Chamber of Physicians, German Parkinson Society, University Hospital W\u00fcrzburg, Robert-Koch-Institute, German Heart Foundation, Federal Joint Committee (G-BA) within the Innovationfond, University Hospital Heidelberg (within RASUNOA-prime; supported by an unrestricted research grant to the University Hospital Heidelberg from Bayer, BMS, Boehringer-Ingelheim, Daiichi Sankyo), Charit\u00e9\u2013Universit\u00e4tsmedizin Berlin (within Mondafis; supported by an unrestricted research grant to the Charit\u00e9 from Bayer), University G\u00f6ttingen (within FIND-AF randomized; supported by an unrestricted research grant to the University G\u00f6ttingen from Boehringer-Ingelheim), outside the submitted work. HF reports grants from German Ministry of Research and Education, German Ministry of Health, Bavarian State Ministry of the Environment and Public Health, German Research Foundation, Federal Joint Committee (G-BA) within the Innovationsfond, German Statutory Pension Insurance, German Statutory Accident Insurance, Network of Rehabilitation Research in Bavaria, German Cancer Aid, outside the submitted work. KK and DW had grant support from the European Society of Cardiology. KK received travel grants from Roche and Boehringer Ingelheim, and DW reports honoraria for invited lectures or advisory boards: AstraZeneca, Merck Sharp and Dohme, Kowa Pharmaceuticals, Menarini, and Zentiva; and consultancy: Merck Sharp and Dohme. GE reports research grants from the German Ministry of Education and Research (BMBF), Lundbeck non-financial support, Bayer grants, and Novartis grants and personal fees. RL received speaker honoraria from Edwards Lifesciences and Stryker. StS reports research grants from the German Ministry of Education and Research, European Union, and University Hospital W\u00fcrzburg; participation in Data Safety Monitoring and Event Adjudication Boards in trials sponsored by Roche and Medtronic; principal investigator in trials sponsored by Bayer, Boehringer, Novartis; speaker honoraria by and advisory board activities for AstraZeneca, Bayer, Boehringer, Novartis, Servier, and Pfizer. DG included elements of this publication in his doctoral thesis. MW and WK have nothing to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"152"}}